Imaging-based evaluation of cardiac structure and function remains paramount in the diagnosis and monitoring of congenital heart disease in childhood. Accurate measurements of intra-and extracardiac hemodynamics are required to inform decision making, allowing planned timing of interventions prior to deterioration of cardiac function. Four-dimensional flow magnetic resonance imaging is a nonionizing noninvasive technology that allows accurate and reproducible delineation of blood flow at any anatomical location within the imaging volume of interest, and also permits derivation of physiological parameters such as kinetic energy and wall shear stress. Four-dimensional flow is the focus of a great deal of attention in adult medicine, however, the translation of this imaging technique into the pediatric population has been limited to date. A more broad-scaled application of 4-dimensional flow in pediatric congenital heart disease stands to increase our fundamental understanding of the cause and significance of abnormal blood flow patterns, may improve risk stratification, and inform the design and use of surgical and percutaneous correction techniques. This paper seeks to outline the application of 4-dimensional flow in the assessment and management of the pediatric population affected by congenital heart disease.
Introduction
Cardiac abnormalities are amongst the most common forms of congenital disease, with a prevalence of 6-10 per 1000 births. [1] [2] [3] Together, they represent a significant disease burden; in Australia, up to a third of children with congenital heart disease (CHD) will undergo a surgical or catheter-based intervention in the first year of life, with multiple subsequent associated hospital and intensive care unit admissions. 1, 4 Cardiac imaging provides an important adjunct to clinical evaluation, contributing to a precise diagnosis as well as providing an accurate means to monitor progression and guide treatment decisions in these children. Magnetic resonance imaging (MRI) is considered the gold standard imaging modality, and has considerably improved structural and functional assessment and reduced the need for invasive procedures. The development of 4-dimensional flow (4D-flow) techniques offers the potential to take another substantial step forward from current capabilities. 4D-flow provides a time-resolved 3-dimensional description of the total dynamics of thoracic flow, allowing comprehensive retrospective analysis of any anatomical location within the scanned ventriculoatrial and vascular system. This review will introduce the capabilities and clinical potential of this technique as applied to assessing CHD in the clinic.
Imaging and characterization of flow in pediatric CHD using traditional techniques
The primary imaging modalities currently utilized in the pediatric CHD setting are echocardiography, computed tomography (CT), MRI, and angiography. Echocardiography, including Doppler flow assessment, remains the clinical standard for routine and pointof-care cardiac evaluation. This noninvasive and cost-effective modality provides bedside assessment of cardiac structures, physiology, and flow. 5 Although echocardiography offers high-quality temporal and spatial information of structural anatomies, its utility in quantitative analysis of flow is subject to well-known limitations. Primary among these are a strong dependence on chest wall anatomy, operator skill, inter-and intraobserver variability, and the fundamental 2-dimensional nature of the technique. Cardiac CT permits detailed examination of cardiac structures, however, the information gained is largely structural, and although dynamic images can be acquired, this is at the cost of increased radiation dose. Cardiac CT has still not been widely adopted in the pediatric population, due to concerns about the impact of radiation exposure.
Cardiac angiography has a clear role in diagnostics and intervention for CHD and until recently, the information it provided on cardiac chamber pressures and blood flow were unattainable by noninvasive means. Angiography affords the opportunity to intervene at the time of assessment, and the scope of this intervention is increasing with advances in percutaneous closure devices and prosthetic heart valves. Given its invasive nature and associated ionizing radiation, angiography is undesirable for routine follow-up. Thus over the past decade, it has changed from a front-line diagnostic tool to use for intervention alone in both adult and pediatric settings. [5] [6] [7] Cardiac MRI has been widely adopted in the CHD setting due to its ability to characterize anatomy, function, blood flow, and tissue dynamics through the use of protocols that include cine acquisitions in various orientations, flow quantitation using phase-contrast velocity encoding, and angiographic data after administration of intravenous contrast. Cardiac MRI is free from ionizing radiation, which combined with the high degree of reproducibility of structural and functional measurements, 8, 9 make it a suitable tool for a reference standard and for the sequential monitoring often required in the pediatric CHD population.
Despite advances in conventional noninvasive imaging methods for the pediatric CHD population, there are still significant gaps in the information obtained, particularly regarding assessment of energetics and complex flow patterns. Many derived metrics have only an indirect relationship to the pathological process they are designed to reflect. For example, in diastolic flow assessment, where multiple reference measures and considerable operator skill are required for complete interpretation.
4D-flow MRI
4D-flow MRI represents a new diagnostic tool capable of complete characterization of flow in a given volume, termed the flow vector field, rather than at a focal anatomical site as is the case in conventional phase-contrast flow imaging. 4D-flow is an extension of the phase-contrast MRI technique used in conventional cardiac MRI to measure flow in a single plane ( Figure 1 ). While available for over a decade, advances in MRI hardware have meant that 4D-flow scan times and quality have only recently become clinically acceptable. It can now be undertaken as an adjunct to conventional MRI, with the addition of 10-15 min of scanning time. 4D-flow involves undertaking phasecontrast acquisition in 3 orthogonal directions over a prescribed volume under free-breathing or diaphragm navigator-gated conditions. Prospectively or retrospectively electrocardiographically gated data are acquired over hundreds of heartbeats to reconstruct a single representative heart cycle. Provided timely analysis is available, 4D-flow could replace the often multiple planar flow acquisitions across the different vessels in a complex congenital case.
One of the major advantages of 4D-flow is the ability to retrospectively interrogate the dataset to obtain many different physiological parameters. While validation studies are underway, the richness of this dataset promises to revolutionize the way in which we characterize the individual hemodynamics of patients. Parameters derived using 4D-flow from healthy adult populations include blood flow velocity, helix and vortex formation, kinetic energy, and wall shear stress ( Figure 2) . [10] [11] [12] [13] [14] [15] The accuracy of flow rates is comparable to preexisting techniques such as echocardiography, with better inter-and intra-observer reproducibility. 16 This has been validated using 2-dimensional phase-contrast MRI and ultrasound measurements, including work using controlled flow loops with an ultrasonic flow transducer and computational fluid dynamics (CFD). [17] [18] [19] [20] [21] [22] High levels of internal consistency have been demonstrated, as evidenced by correlating measured net pulmonary outflow tract blood flow with measured net aortic blood flow. 22, 23 The accuracy and comprehensive nature of 4D-flow has led to its application in a broad range of noncardiac scenarios where accurate understanding of hemodynamics is clinically integral, 24 such as assessing portal and hepatic blood flow in patients with cirrhosis, 25 and intracranial blood vessel malformations. 26, 27 4D-flow measurements in structurally abnormal adult hearts Early clinical studies have applied 4D-flow to evaluating hemodynamics in adults with congenital and acquired structural heart disease, such as valvular heart disease, dilated cardiomyopathy, and ischemic heart disease. 10, 12, [28] [29] [30] [31] [32] [33] [34] [35] [36] Control populations, reproducibility, and longitudinal follow-up have been included. The utility of 4D-flow in identifying blood flow and kinetic energy abnormalities and in measuring increased wall shear stress that predispose to later dilatation and dysfunction in these populations is gaining increasing evidence. 28, 30, 32 A recent consensus guideline on the use of 4D-flow in the adult setting has been developed. 15 Current clinical applications of 4D-flow in pediatric congenital heart disease The pediatric population with complex CHD perhaps represent one of the most important groups with the potential to benefit from the application of 4D-flow. Many of the surgical interventions performed are associated with planned reoperations such as staged repair of single-ventricle circulation and replacement of right ventricle-to-pulmonary artery conduits. Altered blood flow in this setting is postulated to contribute to deteriorating cardiac function. This includes via excessive dissipation of blood inflow energy, inefficiency in transfer of ventricular contraction to systolic ejection kinetic energy, and energy losses during mass transfer across abnormal valves and conduits. The quantitative nature of 4D-flow MRI is well placed to provide new insights into these processes on an individual as well as a disease-specific level.
There has been limited work applying 4D-flow to pediatric congenital populations to date; the literature exploring the use of 4D-flow in pediatric CHD is limited exclusively to case reports and series to date. Right heart and pulmonary artery flow has been examined in a small number of individuals, both in the setting of tetralogy of Fallot and following the Ross procedure. Compared to control groups, individuals with tetralogy of Fallot were shown to have severe vortex formation and retrograde flow in the right ventricular outflow tract and pulmonary arteries, contributing to wall shear stress. Variation in the type of blood flow abnormality by type of original repair performed was evidenced. 23, 31, 37 There have been a handful of case reports and case series in patients with single-ventricle circulation.
22,38-42 4D-flow data allowed identification of the respective contributions of superior and inferior vena caval blood to the pulmonary circulation as well as differences in blood flow velocities between extracardiac and lateral tunnel repair in this setting. 22, 38, 40 4D-flow has been used for serial studies of flow through abnormal aortic valves. 43 Other conditions explored in limited numbers of children include atrial septal defect and aortic flow in the setting of Marfan syndrome. 34, 44 4D-flow analysis in a premature infant with persistent patent ductus arteriosus (PDA) demonstrated the ability to use this technology in free-breathing non-sedated individuals. 45 The applications of 4D-flow in pediatric CHD to date is summarized by disease type in Table 1 . Despite the small body of data, 4D-flow has demonstrated encouraging internal validity as well as understanding of normal cardiac blood flow patterns in neonates, children, and young adults through the use of control groups, 22, 23, 37, 41, 46 and comparisons with conventional 2D-flow assessment. 47 Future directions: Key specific potential applications of 4D-flow in pediatric CHD While it remains novel, the application of 4D-flow MRI to the pediatric CHD population promises advances in understanding of disease, improvement in disease monitoring, and an aid to surgical management.
Information from 4D-flow imaging allows definition of kinetic energy in both the pulmonary and systemic circulations and calculation of energy transfer between these, as well as points of energy loss. For this reason, it is expected to play an increasing role in the assessment of global energy efficiency and kinetics in abnormal hearts, decreasing reliance on models. For example, 4D-flow MRI was undertaken in 6 individuals with total cavopulmonary connection and 6 with normal hearts, illustrating in vivo the variation in kinetic energy loss across the cardiac cycle between groups. Information obtained supports the hypothesis that individuals with a single right ventricle have higher system inefficiency than those with a single left ventricle. 41 4D-flow has also been used to quantify energy loss due to turbulent flow around areas of aortic stenosis. 48 Blood flow through conduits is another obvious target of 4D-flow technology (Figure 3) . Aortic branch-to-pulmonary artery (Blalock-Taussig) shunts or right ventricle-to-pulmonary artery shunts may experience dysfunction such as occlusion or more subtle abnormalities such as irregularity in blood flow, detrimentally impacting circulation in these children. Accurate delineation of shunt blood flow is expected to improve understanding of the natural history of cardiac decompensation in abnormal hearts. This is pertinent given the postulated link between flow abnormalities, altered shear wall stress in vasculature, and later dysfunction. 28, 30, 32 Longitudinal work to ascertain the impact of various conduit and shunt blood flow patterns is needed.
The perceived accuracy and reproducibility of measurements of blood flow, including blood velocity, kinetic energy transfer, and viscous energy dissipation obtained using 4D-flow MRI lend its application in pre-surgical assessment and design of the surgical procedure. [17] [18] [19] [20] [21] [22] [23] In an experimental capacity, data from 4D-flow has already been used to confirm the efficacy of surgical repair and identify pre-and postoperative alternations in hemodynamics, as shown in Figure 4 , the repair of an aortic aneurysm. Given that 4D-flow data in patients with complex cardiac physiology is increasingly providing information previously unobtainable via noninvasive means, 39, 40 it is hoped to provide assistance in surgical planning in this setting.
Perhaps the most exciting application of 4D-flow is in the design of prostheses and the surgical approach for children with complex CHD. CFD has provided the ability to investigate the fluid dynamics associated with a specific intervention and compare the outcomes of various options. Previously, surgeons have relied on parameters ascertained from conventional imaging or modelled using replicas of patients' anatomy, including using 3D print technology to guide the CFD simulations. 49 4D-flow allows more accurate assessment of boundary conditions and a higher degree of patient Table 1 . Recent studies applying 4D magnetic resonance imaging to the pediatric (age < 16 years) congenital heart disease population. specificity in predicting the impact of surgical repair, 50 including when compared to currently available 2D methods. Small studies to date have demonstrated promise in this area. [51] [52] [53] Recent work showing modelling of aortic valve replacement can be seen in Figure 5 .
Study

Current limitations of 4-dimensional magnetic resonance imaging
Limitations of 4D-flow range from technical to theoretical. Technical limitations are reflected in the potential sources of error, including underestimation of high flow velocities due to limited spatial and temporal resolution and systematic errors secondary to gradient imperfections and possible motion artefacts. Imaging of blood flow velocity can be problematic because prior knowledge of expected blood flow velocities is required. Further optimization of sequences and timing is needed to address issues such as limited spatial and temporal resolution and the effects of averaging across multiple respiratory and cardiac cycles. The advent of improved acceleration techniques, improved respiratory and cardiac triggering, as well as multi-velocity encoding approaches and low-flow characterization provide possibilities for ameliorating these problems. 54 Application of 4D-flow to the pediatric population is also currently limited by patient factors, cost, and access to resources and expertise. To date, only a small number of children have been imaged with limited follow-up; larger longitudinal studies are needed. As the 4D-flow component of the study may take up to 20 min, and the total cardiac MRI examination up to an hour, children may require sedation. Some intracardiac devices are not MRI-compatible, although the development of MRIcompatible devices is evolving rapidly. 4D-flow MRI also acquires large datasets requiring computationally intensive analysis with appropriate expertise and software. These issues have all contributed to an impeded adoption of 4D-flow for widespread clinical use. However, as both technology and evidence evolve, 4D-flow is expected to represent a potential strategy to minimize cost, exposure to ionizing radiation, and the need for invasive procedures with prolonged sedation while still maintaining appropriate information yield.
Conclusion
4D-flow MRI presents an important adjunct in the evaluation and management of complex pediatric CHD. The detailed anatomical information provided by standard MRI in this setting is enhanced with the addition of 4D-flow assessment, including the ability to delineate blood flow and derive kinetic energy loss and wall shear stress in the structurally abnormal heart and following intracardiac repair. Increasing understanding of the cause and significance of abnormal blood flow patterns in the heart is expected to contribute to improved risk stratification of patients for management, as well as the potential to inform surgical and percutaneous correction techniques in the future.
